The continuing burden of Rh disease 50 years after the introduction of anti-Rh(D) immunoglobin prophylaxis: call to action

FIGO Committee Safe Motherhood and Newborn Health

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

Severe morbidity and death because of Rh disease have only been reduced by approximately 50% globally during the last 50 years, despite the advent of anti-Rh(D) immunoglobin prophylaxis, which has resulted in >160,000 perinatal deaths and 100,000 disabilities annually. This apparent failure to take appropriate preventive measures is of great concern. Thus, there is a great need to do much better. We wish to draw attention to the unnecessary continuing burden of Rh disease, to discuss some of the reasons for this failure, and to provide suggestions for a better way forward.

Original languageEnglish
Pages (from-to)227.e1-227.e4
JournalAmerican Journal of Obstetrics and Gynecology
Volume221
Issue number3
DOIs
Publication statusPublished - Sept 2019

Keywords

  • alloimmunization
  • blood groups
  • fetal anemia
  • hemolysis
  • hemolytic disease of the fetus and newborn
  • hyperbilirubinemia
  • isoimmunization
  • prevention
  • Rh disease

Fingerprint

Dive into the research topics of 'The continuing burden of Rh disease 50 years after the introduction of anti-Rh(D) immunoglobin prophylaxis: call to action'. Together they form a unique fingerprint.

Cite this